Mdclone Raises $63 Million In Series C Funding To Fuel Global Growth

Mar 01, 2022•over 3 years ago

Amount Raised

$63 Million

Round Type

series c

Description

MDClone, a digital health company, today announced a $63 million Series C round of funding, led by two new investors Warburg Pincus, a leading global growth investor, and Viola Growth, Israel’s leading growth fund, with participation from existing investors aMoon, LightSpeed Venture Partners, and OrbiMed.

Company Information

Company

Md Clone

About

MDClone offers an innovative, self-service data analytics environment powering exploration, discovery, and collaboration throughout the healthcare ecosystems, cross-institutionally, and globally. The powerful underlying infrastructure of the MDClone ADAMS Platform allows users to overcome common barriers in healthcare in order to organize, access and protect the privacy of patient data while accelerating research, improving operations and quality, and driving innovation to deliver better patient outcomes. Founded in Israel in 2016, MDClone serves major health systems, payers, and life science customers in the United States, Canada, and Israel. For more information, visit mdclone.com.

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Mdclone Raises $63 Million In Series C Funding To Fuel Global Growth

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Company Information